Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales Oct 29, 2026 · Cris Tolomia Lilly's revenue guidance rises to $91 billion to $92 billion from $85 billion to $87 billion as quarterly sales climb 39% Read more »